Meibomian gland dysfunction patients with novel Sjögren’s syndrome biomarkers benefit significantly from a single vectored thermal pulsation procedure: a retrospective analysis

Figures & data

Figure 1 Effect of LipiFlow treatment on meibomian gland secretion (MGS) score of Sjögren’s syndrome (SS)-positive and SS-negative patients.

Figure 2 Effect of LipiFlow treatment on Standard Patient Evaluation of Eye Dryness (SPEED) score of Sjögren’s syndrome (SS)-positive and SS-negative patients.

Figure 3 Effect of LipiFlow treatment on tear breakup time (TBUT) of Sjögren’s syndrome (SS)-positive and SS-negative patients.